Singapore markets closed

NeuroScientific Biopharmaceuticals Limited (NSB.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0400+0.0010 (+2.56%)
At close: 03:40PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Operating expenses
Research development
1,362
4,026
7,220
2,218
1,423
-
Selling general and administrative
1,436
1,766
2,733
1,575
1,152
-
Total operating expenses
3,161
6,124
10,504
4,224
2,941
-
Operating income or loss
-4,320
-6,124
-10,504
-4,224
-2,941
-
Interest expense
-
4.734
-
0.063
3.417
-
Total other income/expenses net
40.54
4,953
-
1,018
40.54
33.849
Income before tax
761.172
-1,069
-10,435
-3,178
-2,869
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
761.172
-1,069
-10,435
-3,178
-2,869
-
Net income
761.172
-1,069
-10,435
-3,178
-2,869
-
Net income available to common shareholders
761.172
-1,069
-10,435
-3,178
-2,869
-
Basic EPS
-0.05
-0.01
-0.07
-0.02
-0.04
-
Diluted EPS
-0.05
-0.01
-0.07
-0.02
-0.04
-
Basic average shares
143,472
143,472
143,472
143,472
78,385
-
Diluted average shares
143,472
143,472
143,472
143,472
78,385
-